These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 23567080

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
    Du Y, Wang Q, Zhang X, Wang X, Qin C, Sheng Z, Yin H, Jiang C, Li J, Xu T.
    J Exp Clin Cancer Res; 2017 May 12; 36(1):66. PubMed ID: 28494778
    [Abstract] [Full Text] [Related]

  • 3. Lysophosphatidylcholine acyltransferase 1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.
    Shen L, Gu P, Qiu C, Ding WT, Zhang L, Cao WY, Li ZY, Yan B, Sun X.
    Ann Hepatol; 2022 May 12; 27(3):100680. PubMed ID: 35108614
    [Abstract] [Full Text] [Related]

  • 4. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
    Shida-Sakazume T, Endo-Sakamoto Y, Unozawa M, Fukumoto C, Shimada K, Kasamatsu A, Ogawara K, Yokoe H, Shiiba M, Tanzawa H, Uzawa K.
    PLoS One; 2015 May 12; 10(3):e0120143. PubMed ID: 25803864
    [Abstract] [Full Text] [Related]

  • 5. Knockdown of LPCAT1 Repressed Hepatocellular Carcinoma Growth and Invasion by Targeting S100A11.
    Sun Q, Fu C, Liu J, Li S, Zheng J.
    Ann Clin Lab Sci; 2023 Mar 12; 53(2):212-221. PubMed ID: 37094849
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of Lysophosphatidylcholine Acyltransferase 1 and Concomitant Lipid Alterations in Gastric Cancer.
    Uehara T, Kikuchi H, Miyazaki S, Iino I, Setoguchi T, Hiramatsu Y, Ohta M, Kamiya K, Morita Y, Tanaka H, Baba S, Hayasaka T, Setou M, Konno H.
    Ann Surg Oncol; 2016 Feb 12; 23 Suppl 2():S206-13. PubMed ID: 25752890
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
    Zhou SL, Dai Z, Zhou ZJ, Wang XY, Yang GH, Wang Z, Huang XW, Fan J, Zhou J.
    Hepatology; 2012 Dec 12; 56(6):2242-54. PubMed ID: 22711685
    [Abstract] [Full Text] [Related]

  • 8. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
    Frau M, Ladu S, Calvisi DF, Simile MM, Bonelli P, Daino L, Tomasi ML, Seddaiu MA, Feo F, Pascale RM.
    J Hepatol; 2011 Jul 12; 55(1):111-9. PubMed ID: 21419759
    [Abstract] [Full Text] [Related]

  • 9. sn-1 Specificity of Lysophosphatidylcholine Acyltransferase-1 Revealed by a Mass Spectrometry-Based Assay.
    Zhao X, Liang J, Chen Z, Jian R, Qian Y, Wang Y, Guo Z, Zhang W, Zhang Y, Yin H, Xia Y.
    Angew Chem Int Ed Engl; 2023 Feb 01; 62(6):e202215556. PubMed ID: 36478519
    [Abstract] [Full Text] [Related]

  • 10. A possible connection between adhesion regulating molecule 1 overexpression and nuclear factor kappa B activity in hepatocarcinogenesis.
    Yang X, Miao X, Wen Y, Hu J, Dai W, Yin B.
    Oncol Rep; 2012 Jul 01; 28(1):283-90. PubMed ID: 22576803
    [Abstract] [Full Text] [Related]

  • 11. LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production.
    Han C, Yu G, Mao Y, Song S, Li L, Zhou L, Wang Z, Liu Y, Li M, Xu B.
    PLoS One; 2020 Jul 01; 15(11):e0240801. PubMed ID: 33137125
    [Abstract] [Full Text] [Related]

  • 12. β-catenin plays a key role in metastasis of human hepatocellular carcinoma.
    Lai TY, Su CC, Kuo WW, Yeh YL, Kuo WH, Tsai FJ, Tsai CH, Weng YJ, Huang CY, Chen LM.
    Oncol Rep; 2011 Aug 01; 26(2):415-22. PubMed ID: 21617877
    [Abstract] [Full Text] [Related]

  • 13. Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma.
    Pan QZ, Pan K, Weng DS, Zhao JJ, Zhang XF, Wang DD, Lv L, Jiang SS, Zheng HX, Xia JC.
    Mol Carcinog; 2015 Aug 01; 54(8):598-607. PubMed ID: 24375474
    [Abstract] [Full Text] [Related]

  • 14. Down-regulation of LPCAT expression increases platelet-activating factor level in cirrhotic rat liver: potential antiinflammatory effect of silybin.
    Stanca E, Serviddio G, Bellanti F, Vendemiale G, Siculella L, Giudetti AM.
    Biochim Biophys Acta; 2013 Dec 01; 1832(12):2019-26. PubMed ID: 23851051
    [Abstract] [Full Text] [Related]

  • 15. Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.
    Wu YM, Liu CH, Hu RH, Huang MJ, Lee JJ, Chen CH, Huang J, Lai HS, Lee PH, Hsu WM, Huang HC, Huang MC.
    Cancer Res; 2011 Dec 01; 71(23):7270-9. PubMed ID: 21990321
    [Abstract] [Full Text] [Related]

  • 16. Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis.
    Tse EY, Ko FC, Tung EK, Chan LK, Lee TK, Ngan ES, Man K, Wong AS, Ng IO, Yam JW.
    J Pathol; 2012 Mar 01; 226(4):645-53. PubMed ID: 22072235
    [Abstract] [Full Text] [Related]

  • 17. A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.
    Cheng L, Han X, Shi Y.
    Am J Physiol Endocrinol Metab; 2009 Dec 01; 297(6):E1276-82. PubMed ID: 19773578
    [Abstract] [Full Text] [Related]

  • 18. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
    Yang LY, Tao YM, Ou DP, Wang W, Chang ZG, Wu F.
    Clin Cancer Res; 2006 Oct 01; 12(19):5673-9. PubMed ID: 17020969
    [Abstract] [Full Text] [Related]

  • 19. Increased expression of ZBP-89 and its prognostic significance in hepatocellular carcinoma.
    Zhang CZ, Cao Y, Yun JP, Chen GG, Lai PB.
    Histopathology; 2012 Jun 01; 60(7):1114-24. PubMed ID: 22372401
    [Abstract] [Full Text] [Related]

  • 20. Lysophosphatidylcholine Acyltransferase 1 (LPCAT1) Specifically Interacts with Phospholipid Transfer Protein StarD10 to Facilitate Surfactant Phospholipid Trafficking in Alveolar Type II Cells.
    Lin S, Ikegami M, Moon C, Naren AP, Shannon JM.
    J Biol Chem; 2015 Jul 24; 290(30):18559-74. PubMed ID: 26048993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.